Search Results - "Stella, Phillip J."

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 by Kornblum, Noah, Zhao, Fengmin, Manola, Judith, Klein, Paula, Ramaswamy, Bhuvaneswari, Brufsky, Adam, Stella, Phillip J, Burnette, Brian, Telli, Melinda, Makower, Della F, Cheema, Puneet, Truica, Cristina I, Wolff, Antonio C, Soori, Gamini S, Haley, Barbara, Wassenaar, Timothy R, Goldstein, Lori J, Miller, Kathy D, Sparano, Joseph A

“…Purpose The mammalian target of rapamycin inhibitor everolimus targets aberrant signaling through the PI3K/AKT/mammalian target of rapamycin pathway, a…”
Get full text

Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes by Loprinzi, C. L.

Get full text

The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer by Schild, Steven E., Mandrekar, Sumithra J., Jatoi, Aminah, McGinnis, William L., Stella, Phillip J., Deming, Richard L., Jett, James R., Garces, Yolanda I., Allen, Katie L., Adjei, Alex A.

“…BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome…”
Get full text

Phase iii evaluation of fluoxetine for treatment of hot flashes by LOPRINZI, Charles L, SLOAN, Jeff A, PEREZ, Edith A, QUELLA, Susan K, STELLA, Phillip J, MAILLIARD, James A, HALYARD, Michele Y, PRUTHI, Sandhya, NOVOTNY, Paul J, RUMMANS, Teresa A

“…Hot flashes can be a prominent problem in women with a history of breast cancer. Given concerns regarding the use of hormonal therapies in such patients, other…”
Get full text

Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer by Sanderson Cox, Lisa, Sloan, Jeff A., Patten, Christi A., Bonner, James A., Geyer, Susan M., McGinnis, William L., Stella, Phillip J., Marks, Randolph S.

“…There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226…”
Get full text

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma by Bonner, James A., McGinnis, William L., Stella, Phillip J., Marschke, Robert F., Sloan, Jeff A., Shaw, Edward G., Mailliard, James A., Creagan, Edward T., Ahuja, Rajender K., Johnson, Patricia A.

“…BACKGROUND A three‐arm Phase III randomized trial was performed to compare response rates, time to local or distant progression, and survival for patients with…”
Get full text

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: Results of a North Central Cancer treatment group Phase III study by BONNER, J. A, MCGINNIS, W. L, STELLA, P. J, MARSCHKE, R. F, SLOAN, J. A, SHAW, E. G, MAILLIARD, J. A, CREAGAN, E. T, AHUJA, R. K, JOHNSON, P. A

“…A three-arm Phase III randomized trial was performed to compare response rates, time to local or distant progression, and survival for patients with…”
Get full text